Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT03178552

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UC Davis Sacramento, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • SCRI Florida Cancer Specialists South Fort Myers, Florida, United States
  • Florida Cancer Specialist, North Region St. Petersburg, Florida, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

NCT04351555

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Santa Monica, California, United States
View all 158 locations
View Trial Details
Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT04449874

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667

Conditions
Advanced or Metastatic Non-Small-Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Arizona Oncology Associates,Substudy-02 Tucson, Arizona, United States
  • Fort Wayne Medical Oncology and Hematology, Inc.,Substudy-03 Fort Wayne, Indiana, United States
  • Baptist Health Lexington,Substudy-03 Lexington, Kentucky, United States
  • Washington University School of Medicine - Siteman Cancer Center,Substudy-01 St Louis, Missouri, United States
View all 89 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

NCT04736173

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Research Site Columbus, Georgia, United States
  • Research Site Kingwood, Texas, United States
  • Research Site Blacksburg, Virginia, United States
  • Research Site Hong Kong
View all 39 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

NCT04938817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0152) Gilbert, Arizona, United States
  • Northside Hospital-Northside Hospital Oncology Network ( Site 0156) Atlanta, Georgia, United States
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0180) Fort Wayne, Indiana, United States
  • Baptist Health Lexington-Research ( Site 0158) Lexington, Kentucky, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details

Related conditions